Found 1077 clinical trials
Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer
Doctors leading this study will give blood tests to head and neck cancer participants during the beginning of chemotherapy treatment (also known as induction therapy) to see if these blood tests
- 0 views
- 24 Nov, 2021
- 1 location
Omega-3 Hydrogel and Prevention of Oral Mucositis
Oral mucositis (OM) is recognized as one of the most frequent debilitating sequela encountered by head and neck cancer (HNC) patients treated by radiotherapy. The objective of the study is to
- 0 views
- 12 Mar, 2022
- 1 location
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Radiation Care Gel
The radiotherapy after surgery reduces the risk of recurrence and death is widely used for standard treatment for cancer including breast cancer and head and neck cancer. However, radiation
- 0 views
- 15 Aug, 2021
- 1 location
The Effect of Hyperbaric Oxygen Treatment in Patients With Osteoradionecrosis.
Osteoradionecrosis (ORN) is a severe delayed radiation-induced injury that can occur in patients whom have been subjected to radiotherapy for head and neck cancer. Hyperbaric oxygen treatment
- 0 views
- 28 Jun, 2021
- 2 locations
IORT in Local Advanced Laryngocarcinoma (ILAL)
radiotherapy (IORT) in head and neck cancer has been demonstrated in multiple institutional (3-5) studies to optimize local control. It is still unclear whether IORT can improve the local control and have
- 0 views
- 27 Feb, 2022
- 1 location
Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.
2 randomized controlled trial is to determine the optimal dosage and effectiveness of intratympanic NAC injection in reducing hearing loss in head & neck cancer patients receiving cisplatin
- 3 views
- 28 Feb, 2022
- 1 location
Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLC
Combination treatment of Durvalumab with chemoradiotherapy is ongoing for head/neck cancer, renal cell carcinoma, melanoma, and non-small cell lung cancer (NCT02318771) and pancreatic cancer
- 0 views
- 23 Jan, 2021
- 1 location
NPC - AXEL Study : Axitinib-Avelumab
Nasopharyngeal cancer (NPC) is the most common head and neck cancer in South China and South East Asia. Worldwide, there are 80,000 incident cases and 50,000 deaths annually. In Hong Kong, NPC
- 0 views
- 14 May, 2021
- 1 location
A Study to Learn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in Adults
Researchers are looking for a better way to treat advanced solid cancers including head and neck cancer, lung cancer and bladder cancer. In some people with cancer a protein called Aryl
- 2 views
- 08 Jun, 2022
- 4 locations
Inhibition of Oral Tumorigenesis by Antitumor B
This is a randomized, double-blinded, placebo-control window of opportunity study of Anti-tumor B versus placebo. Anti-tumor B is a botanical agent composed of six Chinese herbs: Sophora tonkinensis, Polygonum bistorta, Prunella vulgaris, Sonchus brachyotus, Dictamnus dasycarpus, and Dioscorea bulbifera.
- 0 views
- 16 May, 2022
- 1 location